...
首页> 外文期刊>Journal of nanoparticle research: An interdisciplinary forum for nanoscale science and technology >Design and development of hyaluronan-functionalized polybenzofulvene nanoparticles as CD44 receptor mediated drug delivery system
【24h】

Design and development of hyaluronan-functionalized polybenzofulvene nanoparticles as CD44 receptor mediated drug delivery system

机译:透明质酸官能化聚苯甲酰氯纳米粒子的设计与发展,作为CD44受体介导的药物递送系统

获取原文
获取原文并翻译 | 示例
           

摘要

A tri-component polymer brush (TCPB), composed of a polybenzofulvene copolymer bearing low molecular weight hyaluronic acid (HA) on the surface of its cylindrical brush-like backbone and oligo-PEG fractions, was employed in the preparation of 350 nm nanostructured drug delivery systems capable of delivering the anticancer drug doxorubicin. The obtained drug delivery systems were characterized on the basis of drug loading and release, dimensions and zeta potential, morphology and in vitro cell activity, and uptake on three different human cell lines, namely the bronchial epithelial 16HBE, the breast adenocarcinoma MCF-7, and the colon cancer HCT116 cells. Finally, the ability of doxorubicin-loaded TCPB nanoparticles (DOXO-TCPB) to be internalized into cancer cells by CD44 receptor mediated uptake was assessed by means of uptake studies in HCT cells. These data were supported by anti-CD44-FITC staining assay. The proposed TCPB nanostructured drug delivery systems have many potential applications in nanomedicine, including cancer targeted drug delivery.
机译:在制备350nm纳米结构药物中,使用由轴承低分子量透明质酸(HA)的聚吲哚酮酸(HA)组成的三组分聚合物刷(TCPB)。制备350nm纳米结构药物能够提供抗癌药物的递送系统。所得药物递送系统的特征在于药物载荷和释放,尺寸和ζ电位,形态和体外细胞活性,以及​​在三种不同的人细胞系上摄取,即支气管上皮16HBE,乳腺腺癌MCF-7,和结肠癌HCT116细胞。最后,通过在HCT细胞中的摄取研究评估了CD44受体介导的摄入的CD44受体介导的癌细胞内化进入癌细胞的能力。抗CD44-FITC染色试验支持这些数据。所提出的TCPB纳米结构药物递送系统在纳米胺的潜在应用中具有许多潜在的应用,包括癌症靶向药物递送。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号